Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IndaPharma is a German biotechnology company specializing in the development and commercialization of advanced formulations of Indocyanine Green (ICG) for medical imaging and diagnostics. A spin-off from the University Medical Center Hamburg-Eppendorf (UKE), the company focuses on enhancing the stability and precision of fluorescence-guided surgery and diagnostic procedures. Their lead products are designed to improve visualization in oncology, hepatology, and ophthalmology, providing surgeons with real-time, high-contrast imaging of anatomical structures and blood flow. IndaPharma's technology addresses critical needs in intraoperative navigation, particularly for sentinel lymph node mapping and solid tumor resection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INDAPharma.